• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Hypertension: A Companion to Braunwald's Heart Disease

Hypertension: A Companion to Braunwald's Heart Disease

9781437727661
700.56 zł
630.50 zł Save 70.06 zł Tax included
Lowest price within 30 days before promotion: 630.50 zł
Quantity
Product unavailable
Out of print

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
Clinical hypertension is one of the most serious long-term problems associated with heart disease. This companion to BRAUNWALDS HEART DISEASE focuses in depth on this key area of cardiovascular medicine. Complete with practical clinical tools for management, it helps you manage the chronic problems of your hypertensive patients. It covers everything from epidemiology and pathophysiology through diagnosis, risk stratification, treatment, outcome studies, concomitant diseases, special populations and special situations, and future treatments.
Product Details
Saunders
51135
9781437727661
9781437727661

Data sheet

Publication date
2012
Issue number
2
Cover
hard cover
Pages count
488
Dimensions (mm)
222 x 281
Weight (g)
1460
  • SECTION I: EPIDEMIOLOGY AND PATHOPHYSIOLOGY

    1 Epidemiology of Hypertension

    2 Pathogenesis of Hypertension

    SECTION II: DIAGNOSIS

    3 Defining Hypertension

    4 Office Blood Pressure Measurement

    5 Home Monitoring of Blood Pressure

    6 Ambulatory Blood Pressure Monitoring in Clinical Hypertension Management

    7 White Coat and Masked Hypertension

    8 Secondary Hypertension: Renovascular Hypertension

    9 Secondary Hypertension: Renin-Independent Mineralocorticoid Excess States

    10 Secondary Hypertension: Pheochromocytoma

    11 Secondary Hypertension: Sleep Apnea

    12 Rare and Unusual Forms of Hypertension

    SECTION III: RISK STRATIFICATION

    13 The Natural History of Untreated Hypertension

    14 The Special Problem of Isolated Systolic Hypertension 

    15 Assessment of Hypertensive Target Organ Damage

    16 Prediction of Global Cardiovascular Risk in Hypertension

    SECTION IV: TREATMENT

    17 Diet and Blood Pressure

    18 Diuretic Therapy in Cardiovascular Disease

    19 ?-Blockers in Hypertension

    20 Angiotensin-Converting Enzyme Inhibitors

    21 Angiotensin Receptor Blockers

    22 Calcium Channel Blockers in Hypertension

    23 ?-Blockers

    24 New Drugs for Hypertension

    25 Devices for Hypertension

    SECTION V: OUTCOME STUDIES

    26 Design of Outcomes Studies

    27 Meta-Analyses of Hypertension Trials: The Blood Pressure Lowering Treatment Trialists Collaboration

    SECTION VI: HYPERTENSION AND CONCOMITANT DISEASES

    28 Ischemic Heart Disease in Hypertension

    29 Heart Failure in Hypertension

    30 Kidney Disease in Hypertension

    31 Transplant Hypertension

    32 Obesity in Hypertension

    33 Peripheral Artery Disease in Hypertension

    34 Cerebrovascular Disease in Hypertension

    35 Hypertension and Diabetes Mellitus: An Update

    36 Dyslipidemia in Hypertension

    SECTION VII: SPECIAL POPULATIONS AND SPECIAL SITUATIONS

    37 Hypertension in Pregnancy

    38 Hypertension in Children and Adolescents

    39 Hypertension in Older Patients

    40 Hypertension in African Americans 

    41 Hypertension in Hispanics

    42 Hypertension in East Asians and Native Hawaiians

    43 Hypertension in South Asians

    44 Resistant Hypertension

    45 Hypertension and the Perioperative Period

    46 Hypertensive Emergencies and Urgencies

    SECTION VIII: HYPERTENSION TREATMENT IN THE FUTURE

    47 Team-Based Care for the Management of Hypertension

    48 Outcomes Research in Hypertension 

    49 Pharmacogenetics of Antihypertensive Treatment

    50 Antihypertensive Drug Development: A Regulatory Perspective

    SECTION IX: GUIDELINES

    51 U.S. and Canadian Hypertension Guidelines

    52 European and British Guidelines on Hypertension

Comments (0)